Tech Company Financing Transactions
Zystor Therapeutics Funding Round
Prolog Ventures joined a $515 thousand funding round for Zystor Therapeutics. The funding round was announced on 9/30/2008.
Transaction Overview
Company Name
Announced On
9/30/2008
Transaction Type
Venture Equity
Amount
$515,000
Round
Undisclosed
Investors
Prolog Ventures (Brian Clevinger)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
10437 Innovation Drive 100
Milwaukee, WI 53226
USA
Milwaukee, WI 53226
USA
Phone
Website
Email Address
Overview
ZyStor Therapeutics, Inc. is a biotechnology company developing innovative therapeutics that will significantly improve the lives of patients who suffer from genetic disorders known as lysosomal storage diseases (LSDs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
George Arida
Chief Executive Officer
Loren Peterson
Chief Scientific Officer
Jonathan LeBowitz
Browse more venture capital transactions:
Prev: 9/30/2008: Greenplum venture capital transaction
Next: 9/30/2008: HeadMix venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs